NcRNAs are involved in the decrease of cytotoxic T cells (CTLs), the lack of sensitivity of IFN-γ signaling, overexpression or loss of PD-1 on the surface of T cells and PD-L1 on the surface of tumor cells, resulting in the development of immune drugs resistance in the organism. The gene discussed is PDCD1; the disease is neoplasm.